IRIS

SCARFO', LYDIA

SCARFO', LYDIA  

Facoltà di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 144 (tempo di esecuzione: 0.032 secondi).
Titolo Data di pubblicazione Autore(i) File
3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells 1-gen-2021 Sbrana, F. V.; Pinos, R.; Barbaglio, F.; Ribezzi, D.; Scagnoli, F.; Scarfo, L.; Redwan, I. N.; Martinez, H.; Fare, S.; Ghia, P.; Scielzo, C.
3D co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents 1-gen-2021 Barbaglio, Federica; Belloni, Daniela; Scarfò, Lydia; Sbrana, Francesca Vittoria; Ponzoni, Maurilio; Bongiovanni, Lucia; Pavesi, Luca; Zambroni, Desiree; Stamatopoulos, Kostas; Caiolfa, Valeria R; Ferrero, Elisabetta; Ghia, Paolo; Scielzo, Cristina
3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B Cells 1-gen-2021 Sampietro, M.; Zamai, M.; Diaz Torres, A.; Labrador Cantarero, V.; Barbaglio, F.; Scarfo', L.; Scielzo, C.; Caiolfa, V. R.
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 1-gen-2020 Carlo-Stella, C.; Delarue, R.; Scarfo', L.; Barde, P. J.; Nair, A.; Locatelli, S. L.; Morello, L.; Magagnoli, M.; Vakkalanka, S.; Viswanadha, S.; Ferreri, A. J. M.
A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia 1-gen-2018 Primo, Daniel; Scarfò, Lydia; Xochelli, Aliki; Mattsson, Mattias; Ranghetti, Pamela; Espinosa, Ana Belén; Robles, Alicia; Gorrochategui, Julian; Martínez-López, Joaquín; de la Serna, Javier; González, Marcos; Gil, Alberto Chaparro; Anguita, Eduardo; Iraheta, Sandra; Munugalavadla, Veerendra; Quéva, Christophe; Tannheimer, Stacey; Rosenquist, Richard; Stamatopoulos, Kostas; Ballesteros, Joan; Ghia, Paolo
A novel Rag2(-/-)gamma(-/-)(c)-xenograft model of human CLL 1-gen-2010 Bertilaccio, Mts; Scielzo, C; Simonetti, G; Ponzoni, M; Apollonio, B; Fazi, C; Scarfo, L; Rocchi, M; Muzio, M; Caligaris-Cappio, F; Ghia, P
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients 1-gen-2015 Tedeschi, A.; Rossi, D.; Motta, M.; Quaresmini, G.; Rossi, M.; Coscia, M.; Anastasia, A.; Rossini, F.; Cortelezzi, A.; Nador, G.; Scarfo', L.; Cairoli, R.; Frustaci, A. M.; Dalceggio, D.; Picardi, P.; de Paoli, L.; Orlandi, E.; Rambaldi, A.; Massaia, M.; Gaidano, G.; Montillo, M.
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression 1-gen-2018 Farinello, Diego; Wozińska, Monika; Lenti, Elisa; Genovese, Luca; Bianchessi, Silvia; Migliori, Edoardo; Sacchetti, Nicolò; Di Lillo, Alessia; Bertilaccio, Maria Teresa Sabrina; De Lalla, Claudia; Valsecchi, Roberta; Gleave, Sabrina Bascones; Lligé, David; Scielzo, Cristina; Mauri, Laura; Ciampa, Maria Grazia; Scarfò, Lydia; Bernardi, Rosa; Lazarevic, Dejan; Gonzalez-Farre, Blanca; Bongiovanni, Lucia; Campo, Elias; Cerutti, Andrea; Ponzoni, Maurilio; Pattini, Linda; Caligaris-Cappio, Federico; Ghia, Paolo; Brendolan, Andrea
A single-tube multiplex method for monitoring mutations in cysteine 481 of Bruton Tyrosine Kinase (BTK) gene in chronic lymphocytic leukemia patients treated with ibrutinib 1-gen-2021 Maffei, R.; Fiorcari, S.; Atene, C. G.; Martinelli, S.; Scarfo, L.; Bonfiglio, S.; Maccaferri, M.; Ljungstrom, V.; Zucchini, P.; Forghieri, F.; Potenza, L.; Ghia, P.; Marasca, R.; Trenti, T.; Tagliafico, E.; Luppi, M.
Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia 1-gen-2021 Ghia, P.; Dlugosz-Danecka, M.; Scarfo, L.; Jurczak, W.
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL 1-gen-2024 Campanella, A; Capasso, A; Heltai, S; Taccetti, C; Albi, E; Herishanu, Y; Haggenburg, S; Chatzikonstantinou, T; Doubek, M; Kättström, M; Giannopoulos, K; Simkovic, M; Moreno, C; Massaia, M; Bumbea, H; Alshemmari, S; Ranghetti, P; Perotta, E; Martini, F; Sant'Antonio, E; Colia, M; Combi, C; Levi, S; Kater, A P; Hazenberg, M; Nijhof, I S; Hofsink, Q; Demosthenous, C; Kotaskova, J; Zaleska, J; Vrbacky, F; Raya, A Mora; Bisogno, D; Tripoli, I E; Popov, V M; Roman, V; Stavroyianni, N; Karypidou, M; Scarano, E; Locatelli, M; Frenquelli, M; Scarfò, L; Stamatopoulos, K; Ghia, P
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial 1-gen-2022 Scarfò, Lydia; Ferrari, Silvia; Frustaci, Anna Maria; Tani, Monica; Bari, Alessia; Scarano, Eloise; Colia, Maria; Ranghetti, Pamela; Angelillo, Piera; Ronchi, Paola; Ponzoni, Maurilio; Ferreri, Andrés J M; Ghia, Paolo
Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia 1-gen-2022 Albi, E.; Capasso, A.; Schiattone, L.; Ghia, P.; Scarfo, L.
Assessing Patients' Knowledge on Chronic Lymphocytic Leukemia: Validation of the ERIC CLL Knowledge Questionnaire in Greece 1-gen-2021 Karamanidou, C.; Xochelli, A.; Papaioannou, M.; Moysiadis, T.; Scarfo, L.; Mattsson, M.; Stavroyianni, N.; Rosenquist, R.; Ghia, P.; Stamatopoulos, K.
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial 1-gen-2024 Tedeschi, A.; Frustaci, A. M.; Condoluci, A.; Coscia, M.; Chiarle, R.; Zinzani, P. L.; Motta, M.; Gaidano, G.; Quaresmini, G.; Scarfo', L.; Catania, G.; Deodato, M.; Jones, R.; Tabanelli, V.; Griggio, V.; Stüssi, G.; Calleri, A.; Pini, K.; Cairoli, R.; Zenz, T.; Signori, A.; Zucca, E.; Rossi, D.; Montillo, M.
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 1-gen-2012 Ponzoni, Maurilio; Kanellis, G; Pouliou, E; Baliakas, P; Scarfò, L; Ferreri, Aj; Doglioni, Claudio; Bikos, V; Dagklis, A; Anagnostopoulos, A; Ghia, PAOLO PROSPERO; Stamatopoulos, K; Papadaki, T.
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib 1-gen-2023 Bonfiglio, Silvia; Sutton, Lesley-Ann; Ljungström, Viktor; Capasso, Antonella; Pandzic, Tatjana; Weström, Simone; Foroughi-Asl, Hassan; Skaftason, Aron; Gellerbring, Anna; Lyander, Anna; Gandini, Francesca; Gaidano, Gianluca; Trentin, Livio; Bonello, Lisa; Reda, Gianluigi; Bödör, Csaba; Stavroyianni, Niki; Tam, Constantine S; Marasca, Roberto; Forconi, Francesco; Panayiotidis, Panayiotis; Ringshausen, Ingo; Jaksic, Ozren; Frustaci, Anna Maria; Iyengar, Sunil; Coscia, Marta; Mulligan, Stephen P; Ysebaert, Loïc; Strugov, Vladimir; Pavlovsky, Carolina; Walewska, Renata; Österborg, Anders; Cortese, Diego; Ranghetti, Pamela; Baliakas, Panagiotis; Stamatopoulos, Kostas; Scarfò, Lydia; Rosenquist, Richard; Ghia, Paolo
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 1-gen-2020 Fiorcari, Stefania; Maffei, Rossana; Vallerini, Daniela; Scarfò, Lydia; Barozzi, Patrizia; Maccaferri, Monica; Potenza, Leonardo; Ghia, Paolo; Luppi, Mario; Marasca, Roberto
Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia 1-gen-2017 Ten Hacken, Elisa; Gounari, Maria; Back, Jaap Willem; Shimanovskaya, Ekaterina; Scarfò, Lydia; Kim, Ekaterina; Burks, Jared; Ponzoni, Maurilio; Ramirez, Giuseppe Alvise; Wierda, William G.; Estrov, Zeev; Keating, Michael J.; Ferrajoli, Alessandra; Stamatopoulos, Kostas; Ghia, Paolo; Burger, Jan A.
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Time to Retire? 1-gen-2019 Scarfo', L.; Tedeschi, A.